Healthcare -
Biotechnology - NASDAQ - US
$ 9.36
-1.06 %
$ 496 M
Market Cap
-4.5
P/E
STOK - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss STOK - Stoke Therapeutics, Inc.
-24 K
LAST VALUE
62.20%
2 YEAR CAGR
42.41%
5 YEAR CAGR
0.00%
10 YEAR CAGR